David Shaw’s Acadia Healthcare ACHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.63M | Sell |
55,336
-39,385
| -42% | -$1.01M | ﹤0.01% | 3369 |
|
|
2026
Q1 | $2.22M | Sell |
94,721
-973,443
| -91% | -$17.6M | ﹤0.01% | 2839 |
|
|
2025
Q4 | $15.2M | Sell |
1,068,164
-1,130,925
| -51% | -$21.4M | 0.01% | 1429 |
|
|
2025
Q3 | $54.4M | Buy |
2,199,089
+571,283
| +35% | +$12.7M | 0.03% | 614 |
|
|
2025
Q2 | $36.9M | Buy |
1,627,806
+563,945
| +53% | +$13.4M | 0.03% | 710 |
|
|
2025
Q1 | $32.3M | Buy |
1,063,861
+520,515
| +96% | +$19.8M | 0.03% | 683 |
|
|
2024
Q4 | $21.5M | Buy |
543,346
+453,093
| +502% | +$20.4M | 0.02% | 993 |
|
|
2024
Q3 | $5.72M | Buy |
90,253
+57,495
| +176% | +$4.15M | ﹤0.01% | 1838 |
|
|
2024
Q2 | $2.21M | Sell |
32,758
-106,988
| -77% | -$7.47M | ﹤0.01% | 2570 |
|
|
2024
Q1 | $11.1M | Buy |
139,746
+7,733
| +6% | +$632K | 0.01% | 1291 |
|
|
2023
Q4 | $10.3M | Buy |
132,013
+29,423
| +29% | +$2.18M | 0.01% | 1340 |
|
|
2023
Q3 | $7.21M | Sell |
102,590
-16,083
| -14% | -$1.2M | 0.01% | 1509 |
|
|
2023
Q2 | $9.45M | Buy |
118,673
+46,761
| +65% | +$3.38M | 0.01% | 1386 |
|
|
2023
Q1 | $5.2M | Buy |
71,912
+45,782
| +175% | +$3.57M | 0.01% | 1910 |
|
|
2022
Q4 | $2.15M | Buy |
26,130
+11,181
| +75% | +$922K | ﹤0.01% | 2882 |
|
|
2022
Q3 | $1.17M | Buy |
14,949
+5,965
| +66% | +$477K | ﹤0.01% | 3479 |
|
|
2022
Q2 | $608K | Sell |
8,984
-99,059
| -92% | -$6.91M | ﹤0.01% | 3986 |
|
|
2022
Q1 | $7.08M | Buy |
108,043
+96,202
| +812% | +$5.59M | 0.01% | 1941 |
|
|
2021
Q4 | $719K | Buy |
+11,841
| New | +$706K | ﹤0.01% | 4169 |
|
|
2021
Q3 | – | Sell |
-16,003
| Closed | -$1M | – | 4924 |
|
|
2021
Q2 | $1M | Sell |
16,003
-141,686
| -90% | -$8.88M | ﹤0.01% | 3533 |
|
|
2021
Q1 | $9.01M | Sell |
157,689
-60,278
| -28% | -$3.26M | 0.01% | 1432 |
|
|
2020
Q4 | $11M | Buy |
+217,967
| New | +$8.69M | 0.01% | 1339 |
|
|
2020
Q1 | – | Sell |
-127,024
| Closed | -$4.22M | – | 3876 |
|
|
2019
Q4 | $4.22M | Buy |
+127,024
| New | +$3.98M | ﹤0.01% | 1860 |
|
|
2018
Q1 | – | Sell |
-22,618
| Closed | -$738K | – | 3448 |
|
|
2017
Q4 | $738K | Buy |
+22,618
| New | +$784K | ﹤0.01% | 2751 |
|
|
2015
Q1 | – | Sell |
-29,513
| Closed | -$1.81M | – | 3587 |
|
|
2014
Q4 | $1.81M | Buy |
+29,513
| New | +$1.72M | ﹤0.01% | 2356 |
|
|
2014
Q3 | – | Sell |
-47,490
| Closed | -$2.16M | – | 4058 |
|
|
2014
Q2 | $2.16M | Buy |
+47,490
| New | +$2.09M | ﹤0.01% | 2244 |
|
Other funds holding ACHC
CCM
DM
DCM
FCM
ABI
David Shaw's ACHC Position: Q2 2026 in Review
David Shaw reduced its Acadia Healthcare (ACHC) stake by 42% in Q2 2026, selling an estimated $1.01M and leaving 55,336 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #3369.
David Shaw first reported a position in ACHC in Q2 2014 and has held it in 26 quarters since. The position peaked at $54.4M in Q3 2025. 312 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.
- David Shaw held 55,336 shares of Acadia Healthcare worth $1.63M as of Q2 2026.
- David Shaw sold 39,385 Acadia Healthcare shares in Q2 2026, an estimated $1.01M.
- Acadia Healthcare made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3369 holding.
- David Shaw first reported a position in Acadia Healthcare in Q2 2014 and has held it in 26 quarters since.
- David Shaw's Acadia Healthcare position peaked at $54.4M in Q3 2025.
- 312 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.